The goal of this study is to examine the effectiveness of VR-based respite in improving cognitive function, mental health, and quality of life in caregivers and homebound older adults compared to a control group using videos and a usual care group. Participants are randomly assigned to one of three groups: VR intervention, video control, or usual care. The VR group receives immersive VR sessions using the SilVR Adventures platform. The video group receives non-immersive video sessions with similar content. The usual care group receives no additional intervention. Assessments are conducted at baseline, immediate post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, loneliness, quality of life, and other outcomes. The intervention dosage will be 4 weeks (1 sessions/week; 30 min/session). Secondarily, the study explores differences in effectiveness between caregivers and homebound older adults, and potential moderators or mediators such as baseline health status, technological literacy, and social support.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline in depression and anxiety on PHQ-4 after intervention
Timeframe: Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in quality of life on EQ-5D-5L after intervention
Timeframe: Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in loneliness on UCLA Loneliness Scale after intervention
Timeframe: Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in subjective happiness on Subjective Happiness Scale after intervention
Timeframe: Baseline, Immediate after intervention, and 3 months after intervention